CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2561
-0.0139 (-5.15%)
At close: Dec 30, 2025
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $325.2 million as of December 31, 2025. Its market cap has increased by 107.88% in one year.
Market Cap
325.20M
Enterprise Value
343.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 325.20M, an increase of 5,772.60%. That is a compound annual growth rate of 22.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 325.20M | 141.54% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |
| OpGen | 150.57M |